🇺🇸 FDA
Patent

US 10441567

Methods and compositions for modulating hormone levels

granted A61KA61K31/138A61K31/277

Quick answer

US patent 10441567 (Methods and compositions for modulating hormone levels) held by Ligand Pharmaceuticals Incorporated expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/138, A61K31/277, A61K31/40, A61K31/402